BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24262354)

  • 21. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy.
    Drakos SG; Terrovitis JV; Nanas JN; Charitos EI; Ntalianis AS; Malliaras KG; Diakos N; Koudoumas D; Theodoropoulos S; Yacoub MH; Anastasiou-Nana MI
    Ann Thorac Surg; 2011 Mar; 91(3):764-9. PubMed ID: 21352994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular changes after left ventricular assist device support for heart failure.
    Birks EJ
    Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
    Fieno DS; Czer LS; Schwarz ER; Simsir S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
    Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
    J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.
    Welp H; Rukosujew A; Tjan TD; Hoffmeier A; Kösek V; Scheld HH; Drees G
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S185-8. PubMed ID: 20101537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial recovery and the failing heart: medical, device and mechanical methods.
    Goldfinger JZ; Nair AP
    Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective ventricular unloading by left ventricular assist device varies with stage of heart failure: cardiac simulator study.
    Jhun CS; Reibson JD; Cysyk JP
    ASAIO J; 2011; 57(5):407-13. PubMed ID: 21817896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
    Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
    J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bridge to bridge surgery;conversion from extracorporeal left ventricular assist device to implantable left ventricular assist device].
    Kinoshita O; Ono M
    Kyobu Geka; 2013 Jul; 66(8 Suppl):690-5. PubMed ID: 23917187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.